Home/Pipeline/tLNP CAR‑T

tLNP CAR‑T

Infectious diseases / regenerative medicine

PreclinicalActive

Key Facts

Indication
Infectious diseases / regenerative medicine
Phase
Preclinical
Status
Active
Company

About Taiwan Liposome Company

Taiwanese biotech leveraging next‑gen lipid delivery for pain, metabolic and cell‑therapy medicines.

View full company profile